In lung cancer, inhibiting NINJ1 significantly increased the expression and secretion of IL-6, enhanced cell migration, and ultimately induced a significant increase in the incidence of lung metastasis, as well as the sizes and number of tumor nodules, without affecting tumor growth (74). The gene discussed is IL6; the disease is neoplasm.